XTX Topco Ltd - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
XTX Topco Ltd ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$27,882
-91.7%
46,486
-82.0%
0.01%
-91.7%
Q2 2023$334,955
-7.8%
257,658
+24.9%
0.06%
-21.1%
Q1 2023$363,148
+152.9%
206,334
+351.2%
0.08%
+153.3%
Q4 2022$143,605
-21.1%
45,734
+23.2%
0.03%
-33.3%
Q3 2022$182,00037,1170.04%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
RA Capital Management 6,000,000$66,540,0006.69%
FIC CAPITAL INC 787,529$8,734,0003.47%
RA Capital Management 1,220,209$13,532,0001.36%
PRINCETON CAPITAL MANAGEMENT INC 114,120$1,266,0000.67%
Perceptive Advisors 800,000$8,872,0000.53%
Cormorant Asset Management, LP 361,000$4,003,0000.53%
Highlander Capital Management, LLC 43,500$482,0000.43%
APEX CAPITAL, LLC 439,900$4,878,0000.42%
WASATCH ADVISORS LP 3,091,386$34,283,0000.37%
Baker Brothers Advisors 3,230,932$35,831,0000.31%
View complete list of SANGAMO THERAPEUTICS INC shareholders